Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash | 25.66 | 3.69 | 0.39 | 4.12 |
Cash Equivalents | 5.29 | 0.06 | 2.88 | 12.10 |
Short Term Investments | 174.97 | 128.28 | 175.46 | 38.33 |
Cashand Short Term Investments | 205.92 | 132.02 | 178.73 | 54.54 |
Accounts Receivable- Trade Net | 136.28 | 117.30 | 112.41 | 79.54 |
Total Receivables Net | 136.97 | 117.30 | 117.08 | 83.51 |
Total Inventory | 62.19 | 76.20 | 61.33 | 43.00 |
Other Current Assets Total | 26.22 | 26.93 | 23.20 | 12.04 |
Total Current Assets | 431.29 | 353.54 | 381.65 | 194.31 |
Property/ Plant/ Equipment Total- Net | 180.29 | 122.70 | 98.32 | 95.50 |
Intangibles Net | 4.47 | 1.48 | 0.88 | 0.48 |
Long Term Investments | 4.32 | - | 0.00 | 0.00 |
Other Long Term Assets Total | 5.84 | 51.25 | 10.16 | 5.84 |
Total Assets | 626.21 | 528.98 | 491.01 | 296.12 |
Accounts Payable | 131.51 | 87.74 | 63.23 | 39.93 |
Current Portof LT Debt/ Capital Leases | 1.62 | 1.87 | 6.19 | 31.00 |
Other Currentliabilities Total | 38.62 | 6.01 | 2.81 | 3.35 |
Total Current Liabilities | 171.75 | 121.24 | 93.99 | 93.42 |
Long Term Debt | 0.00 | 0.11 | 0.44 | 0.83 |
Capital Lease Obligations | 2.02 | 3.02 | 0.00 | 0.52 |
Total Long Term Debt | 2.02 | 3.13 | 0.44 | 1.35 |
Total Debt | 3.64 | 4.99 | 6.64 | 32.35 |
Other Liabilities Total | 2.50 | 2.34 | 1.80 | 1.55 |
Total Liabilities | 176.27 | 126.70 | 96.23 | 97.00 |
Common Stock Total | 10.40 | 10.46 | 10.90 | 6.41 |
Retained Earnings( Accumulated Deficit) | 439.54 | 190.41 | 155.13 | 117.22 |
Total Equity | 449.94 | 402.27 | 394.78 | 199.12 |
Total Liabilities Shareholders' Equity | 626.21 | 528.98 | 491.01 | 296.12 |
Total Common Shares Outstanding | 2.08 | 2.09 | 2.18 | 2.18 |
Tangible Book Valueper Share Common Eq | 214.18 | 191.52 | 180.73 | 91.14 |
Prepaid Expenses | - | 1.08 | 1.31 | 1.22 |
Property/ Plant/ Equipment Total- Gross | - | 204.22 | 167.82 | 153.59 |
Accumulated Depreciation Total | - | -81.51 | -69.51 | -58.10 |
Accrued Expenses | - | 25.63 | 21.75 | 19.14 |
Notes Payable/ Short Term Debt | - | 0.00 | 0.00 | 0.00 |
Additional Paid- In Capital | - | 198.62 | 226.95 | 75.49 |
ESOP Debt Guarantee | - | 2.82 | 1.81 | - |
Other Equity Total | - | -0.04 | -0.01 | 0.00 |
Deferred Income Tax | - | - | 0.00 | 0.68 |
Minority Interest | - | - | - | 0.00 |
Windlas Biotech Dividend Windlas Biotech Bonus Windlas Biotech News Windlas Biotech AGM Windlas Biotech Rights Windlas Biotech Splits Windlas Biotech Board Meetings Windlas Biotech Key Metrics Windlas Biotech Shareholdings Windlas Biotech Profit Loss Windlas Biotech Cashflow Windlas Biotech Q1 Results Windlas Biotech Q2 Results Windlas Biotech Q3 Results Windlas Biotech Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks